KENILWORTH, N.J., July 21 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) has rescheduled the time of its conference call and webcast to review the sales and earnings results for the 2008 second quarter to approximately 4:45 p.m. (EDT) from 8 a.m. today. The quarterly financial results will be issued today, July 21, 2008, after the close of the New York Stock Exchange.
Schering-Plough made the second-quarter earnings schedule change because Terje Pedersen, M.D., Ph.D., Chief, Preventive Medicine Clinic, Ulleval University Hospital, Oslo, Norway, and the primary investigator of Simvastatin plus Ezetimibe in Aortic Stenosis study (SEAS), has announced that he will present an update on the study at 1 p.m. (U.S. EDT) today.
To listen live to the Schering-Plough second quarter earnings conference call, dial 1-877-565-9664 or 1-706-634-5003 and enter conference ID #50992673. A replay of the call will be available beginning later on July 21 through 5 p.m. on July 28. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID #50992673. A live audio webcast of the conference call also will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, http://www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available starting on July 21 through 5 p.m. on Aug. 20.
Schering-Plough is an innovation-driven, science-centered global health
care company. Through its own biopharmaceutical research and collaborations
with partners, Schering-Plough creates therapies that help save and improve
lives around the world. The company applies i
|SOURCE Schering-Plough Corporation|
Copyright©2008 PR Newswire.
All rights reserved